Other studies have indicated that METTL3 is downregulated in glioma tissues and regulates U251 cell proliferation and apoptosis by targeting COL4A1 and HSP9, potential therapeutic targets of glioma [54,55]. This evidence concerns the gene METTL3 and central nervous system cancer.